World's Best Scientists 2026 revealed!
Paul J. Conlon

Paul J. Conlon

D-Index & Metrics

Biology and Biochemistry

D-Index
56
Citations
15561
World Ranking
14216
National Ranking
5993

Overview

Paul J. Conlon is affiliated with Bioduro-Sundia in the United States. Their professional activities are centered within this organization, contributing to its research and operational objectives.

No recent papers, co-authors, publication venues, book publications, or specified fields of study and research topics are listed for this scientist in the available data. Consequently, there is no detailed public information on their publication record or collaborative research activities.

Without specific information on recent papers or research topics, it is not possible to outline particular areas of expertise or contributions to scientific fields. The absence of awards information similarly limits insights into formal recognition or distinctions.

The lack of explicit data regarding their main fields of study, subfields, and main topics of work makes it unclear which scientific disciplines or research questions form the primary focus of their career. Likewise, the unavailability of frequent publication venues suggests either limited publication activity or undisclosed records.

As there is no indication that Paul J. Conlon is deceased, the profile is presented in the present tense. Further details about their research impact or specific focus areas require additional publicly available sources or updates to their academic record.

Best Publications

  • Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

    Carl J. March;Bruce Mosley;Alf Larsen;Douglas Pat Cerretti

  • A Short Polypeptide Marker Sequence Useful for Recombinant Protein Identification and Purification.

    Thomas P. Hopp;Kathryn S. Prickett;Virginia L. Price;Randell T. Libby

  • Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo- controlled, randomized phase II trial

    Ludwig Kappos;Giancarlo Comi;Hillel Panitch;Joel Oger

  • Detection and characterization of high affinity plasma membrane receptors for human interleukin 1.

    Steven K. Dower;Shirley R. Kronheim;Carl J. March;Paul J. Conlon

  • Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor.

    R A Black;S R Kronheim;M Cantrell;M C Deeley

  • The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor.

    B Mosley;D L Urdal;K S Prickett;A Larsen

  • High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide.

    H Gazzano-Santoro;J B Parent;L Grinna;A Horwitz

  • Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

    Brocke S;Gijbels K;Allegretta M;Ferber I

  • Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1.

    Diane Y. Mochizuki;June R. Eisenman;Paul J. Conlon;Alf D. Larsen

  • Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy

    Lawrence Steinman;Roland Martin;Claude Charles Andre Bernard;Paul Conlon

  • Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells.

    P J Morrissey;R G Goodwin;R P Nordan;D Anderson

  • Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator.

    Aniko Hever;Richard B. Roth;Peter Hevezi;Maria E. Marin

  • The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia.

    Stefen A. Boehme;Francisco M. Lio;Dominique Maciejewski-Lenoir;Kevin B. Bacon

  • A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin

    David G. Alleva;Paul D. Crowe;Liping Jin;William W. Kwok

  • Effect of IL-7 on the growth of fetal thymocytes in culture.

    J D Watson;P J Morrissey;A E Namen;P J Conlon

  • Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen.

    R B Acres;P J Conlon;D Y Mochizuki;B Gallis

  • Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines.

    Kenneth Grabstein;June Eisenman;Diane Mochizuki;Kurt Shanebeck

  • Murine thymocytes proliferate in direct response to interleukin-7.

    Paul J. Conlon;Philip J. Morrissey;Richard P. Nordan;Kenneth H. Grabstein

  • Immunological Characterization and Therapeutic Activity of an Altered-Peptide Ligand, NBI-6024, Based on the Immunodominant Type 1 Diabetes Autoantigen Insulin B-Chain (9–23) Peptide

    David G. Alleva;Amitabh Gaur;Liping Jin;Dale Wegmann

  • Cutting Edge: Predictable TCR Antigen Recognition Based on Peptide Scans Leads to the Identification of Agonist Ligands with No Sequence Homology

    Bernhard Hemmer;Marco Vergelli;Bruno Gran;Nick Ling

Frequent Co-Authors

Lawrence Steinman
Lawrence Steinman Stanford University
Carl J. March
Carl J. March Amgen (United States)
Kenneth H. Grabstein
Kenneth H. Grabstein Corixa Corporation
Steven Gillis
Steven Gillis Dartmouth College
Douglas Pat Cerretti
Douglas Pat Cerretti Amgen (United States)
Roland Martin
Roland Martin University of Zurich
David Cosman
David Cosman Amgen (United States)
Bernhard Hemmer
Bernhard Hemmer Technical University of Munich
Henry F. McFarland
Henry F. McFarland National Institutes of Health
Jack P. Antel
Jack P. Antel McGill University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Paul J. Conlon

Recently Published Articles